Literature DB >> 29344893

Profiling Tumor Infiltrating Immune Cells with CIBERSORT.

Binbin Chen1, Michael S Khodadoust2,3,4, Chih Long Liu2, Aaron M Newman5,6, Ash A Alizadeh7,8,9,10.   

Abstract

Tumor infiltrating leukocytes (TILs) are an integral component of the tumor microenvironment and have been found to correlate with prognosis and response to therapy. Methods to enumerate immune subsets such as immunohistochemistry or flow cytometry suffer from limitations in phenotypic markers and can be challenging to practically implement and standardize. An alternative approach is to acquire aggregative high dimensional data from cellular mixtures and to subsequently infer the cellular components computationally. We recently described CIBERSORT, a versatile computational method for quantifying cell fractions from bulk tissue gene expression profiles (GEPs). Combining support vector regression with prior knowledge of expression profiles from purified leukocyte subsets, CIBERSORT can accurately estimate the immune composition of a tumor biopsy. In this chapter, we provide a primer on the CIBERSORT method and illustrate its use for characterizing TILs in tumor samples profiled by microarray or RNA-Seq.

Entities:  

Keywords:  Cancer immunology; Deconvolution; Gene expression; Microarray; RNA-Seq; Support vector regression (SVR); TCGA; Tumor heterogeneity; Tumor infiltrating leukocytes (TILs); Tumor microenvironment

Mesh:

Year:  2018        PMID: 29344893      PMCID: PMC5895181          DOI: 10.1007/978-1-4939-7493-1_12

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  22 in total

1.  MMAD: microarray microdissection with analysis of differences is a computational tool for deconvoluting cell type-specific contributions from tissue samples.

Authors:  David A Liebner; Kun Huang; Jeffrey D Parvin
Journal:  Bioinformatics       Date:  2013-10-01       Impact factor: 6.937

2.  BRAF mutation, NRAS mutation, and the absence of an immune-related expressed gene profile predict poor outcome in patients with stage III melanoma.

Authors:  Graham J Mann; Gulietta M Pupo; Anna E Campain; Candace D Carter; Sarah-Jane Schramm; Svetlana Pianova; Sebastien K Gerega; Chitra De Silva; Kenneth Lai; James S Wilmott; Maria Synnott; Peter Hersey; Richard F Kefford; John F Thompson; Yee Hwa Yang; Richard A Scolyer
Journal:  J Invest Dermatol       Date:  2012-08-30       Impact factor: 8.551

3.  Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients.

Authors:  Roy S Herbst; Jean-Charles Soria; Marcin Kowanetz; Gregg D Fine; Omid Hamid; Michael S Gordon; Jeffery A Sosman; David F McDermott; John D Powderly; Scott N Gettinger; Holbrook E K Kohrt; Leora Horn; Donald P Lawrence; Sandra Rost; Maya Leabman; Yuanyuan Xiao; Ahmad Mokatrin; Hartmut Koeppen; Priti S Hegde; Ira Mellman; Daniel S Chen; F Stephen Hodi
Journal:  Nature       Date:  2014-11-27       Impact factor: 49.962

4.  Prognostically relevant gene signatures of high-grade serous ovarian carcinoma.

Authors:  Roel G W Verhaak; Pablo Tamayo; Ji-Yeon Yang; Diana Hubbard; Hailei Zhang; Chad J Creighton; Sian Fereday; Michael Lawrence; Scott L Carter; Craig H Mermel; Aleksandar D Kostic; Dariush Etemadmoghadam; Gordon Saksena; Kristian Cibulskis; Sekhar Duraisamy; Keren Levanon; Carrie Sougnez; Aviad Tsherniak; Sebastian Gomez; Robert Onofrio; Stacey Gabriel; Lynda Chin; Nianxiang Zhang; Paul T Spellman; Yiqun Zhang; Rehan Akbani; Katherine A Hoadley; Ari Kahn; Martin Köbel; David Huntsman; Robert A Soslow; Anna Defazio; Michael J Birrer; Joe W Gray; John N Weinstein; David D Bowtell; Ronny Drapkin; Jill P Mesirov; Gad Getz; Douglas A Levine; Matthew Meyerson
Journal:  J Clin Invest       Date:  2012-12-21       Impact factor: 14.808

Review 5.  The continuum of cancer immunosurveillance: prognostic, predictive, and mechanistic signatures.

Authors:  Jérôme Galon; Helen K Angell; Davide Bedognetti; Francesco M Marincola
Journal:  Immunity       Date:  2013-07-25       Impact factor: 31.745

Review 6.  High-throughput genomic profiling of tumor-infiltrating leukocytes.

Authors:  Aaron M Newman; Ash A Alizadeh
Journal:  Curr Opin Immunol       Date:  2016-06-30       Impact factor: 7.486

7.  Inferring tumour purity and stromal and immune cell admixture from expression data.

Authors:  Kosuke Yoshihara; Maria Shahmoradgoli; Emmanuel Martínez; Rahulsimham Vegesna; Hoon Kim; Wandaliz Torres-Garcia; Victor Treviño; Hui Shen; Peter W Laird; Douglas A Levine; Scott L Carter; Gad Getz; Katherine Stemke-Hale; Gordon B Mills; Roel G W Verhaak
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

8.  PD-1 blockade induces responses by inhibiting adaptive immune resistance.

Authors:  Paul C Tumeh; Christina L Harview; Jennifer H Yearley; I Peter Shintaku; Emma J M Taylor; Lidia Robert; Bartosz Chmielowski; Marko Spasic; Gina Henry; Voicu Ciobanu; Alisha N West; Manuel Carmona; Christine Kivork; Elizabeth Seja; Grace Cherry; Antonio J Gutierrez; Tristan R Grogan; Christine Mateus; Gorana Tomasic; John A Glaspy; Ryan O Emerson; Harlan Robins; Robert H Pierce; David A Elashoff; Caroline Robert; Antoni Ribas
Journal:  Nature       Date:  2014-11-27       Impact factor: 49.962

9.  Copy number loss of the interferon gene cluster in melanomas is linked to reduced T cell infiltrate and poor patient prognosis.

Authors:  Peter S Linsley; Cate Speake; Elizabeth Whalen; Damien Chaussabel
Journal:  PLoS One       Date:  2014-10-14       Impact factor: 3.240

10.  Lineage-specific and single-cell chromatin accessibility charts human hematopoiesis and leukemia evolution.

Authors:  M Ryan Corces; Jason D Buenrostro; Beijing Wu; Peyton G Greenside; Steven M Chan; Julie L Koenig; Michael P Snyder; Jonathan K Pritchard; Anshul Kundaje; William J Greenleaf; Ravindra Majeti; Howard Y Chang
Journal:  Nat Genet       Date:  2016-08-15       Impact factor: 38.330

View more
  691 in total

1.  SITC cancer immunotherapy resource document: a compass in the land of biomarker discovery.

Authors:  Siwen Hu-Lieskovan; Srabani Bhaumik; Kavita Dhodapkar; Jean-Charles J B Grivel; Sumati Gupta; Brent A Hanks; Sylvia Janetzki; Thomas O Kleen; Yoshinobu Koguchi; Amanda W Lund; Cristina Maccalli; Yolanda D Mahnke; Ruslan D Novosiadly; Senthamil R Selvan; Tasha Sims; Yingdong Zhao; Holden T Maecker
Journal:  J Immunother Cancer       Date:  2020-12       Impact factor: 13.751

Review 2.  Immunotherapy and predictive immunologic profile: the tip of the iceberg.

Authors:  Tatiana Cunha Pereira; Paulo Rodrigues-Santos; Jani Sofia Almeida; Fábio Rêgo Salgueiro; Ana Raquel Monteiro; Filipa Macedo; Rita Félix Soares; Isabel Domingues; Paula Jacinto; Gabriela Sousa
Journal:  Med Oncol       Date:  2021-03-31       Impact factor: 3.064

3.  Immune escape mechanisms for TCRLBCL.

Authors:  Wing C Chan
Journal:  Blood       Date:  2021-03-11       Impact factor: 22.113

4.  A review of digital cytometry methods: estimating the relative abundance of cell types in a bulk of cells.

Authors:  Trang Le; Rachel A Aronow; Arkadz Kirshtein; Leili Shahriyari
Journal:  Brief Bioinform       Date:  2021-07-20       Impact factor: 11.622

5.  Gene Expression Studies for the Development of Particle Therapy.

Authors:  Sally A Amundson
Journal:  Int J Part Ther       Date:  2018-09-21

6.  The landscape of CD28, CD80, CD86, CTLA4, and ICOS DNA methylation in head and neck squamous cell carcinomas.

Authors:  Luka de Vos; Ingela Grünwald; Emma Grace Bawden; Jörn Dietrich; Kathrin Scheckenbach; Constanze Wiek; Romina Zarbl; Friedrich Bootz; Jennifer Landsberg; Dimo Dietrich
Journal:  Epigenetics       Date:  2020-04-21       Impact factor: 4.528

7.  Lymphovascular invasion in breast cancer is associated with gene expression signatures of cell proliferation but not lymphangiogenesis or immune response.

Authors:  Mariko Asaoka; Santosh K Patnaik; Frank Zhang; Takashi Ishikawa; Kazuaki Takabe
Journal:  Breast Cancer Res Treat       Date:  2020-04-13       Impact factor: 4.872

8.  Progressive Multiple Sclerosis Transcriptome Deconvolution Indicates Increased M2 Macrophages in Inactive Lesions.

Authors:  Sai Batchu
Journal:  Eur Neurol       Date:  2020-08-28       Impact factor: 1.710

9.  Transcriptomic characterization of microglia activation in a rat model of ischemic stroke.

Authors:  Wenjun Deng; Emiri Mandeville; Yasukazu Terasaki; Wenlu Li; Julie Holder; Aaron Tt Chuang; Mingming Ning; Ken Arai; Eng H Lo; Changhong Xing
Journal:  J Cereb Blood Flow Metab       Date:  2020-06-17       Impact factor: 6.200

10.  Expression pattern, regulation, and clinical significance of TOX in breast cancer.

Authors:  Mohit Arora; Sarita Kumari; Jay Singh; Anita Chopra; Shyam S Chauhan
Journal:  Cancer Immunol Immunother       Date:  2020-08-05       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.